Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
P. A. Winstanley & A. M. Breckenridge. (1987) Currently important antimalarial drugs. Annals of Tropical Medicine & Parasitology 81:5, pages 619-627.
Read now
Read now
A. B. Gilroy. (1952) An Investigation of Proguanil Prophylaxis and Co-Existing Parasitaemia. Annals of Tropical Medicine & Parasitology 46:1, pages 72-84.
Read now
Read now
Articles from other publishers (32)
Kenjiro Okubo, Toshiyuki Kudo, Sae Yoshihara, Yu Nakabayashi, Kana Nakauchi, Akimi Tanaka, Moe Saito, Ayumi Tsujisawa, Hitomi Goda, Yoshiaki Yamagishi, Chinatsu Otake, Kosho Makino, Hideyo Takahashi & Kiyomi Ito. (2023) Physiologically based pharmacokinetic model analysis of the inhibitory effect of vonoprazan on the metabolic activation of proguanil. Drug Metabolism and Pharmacokinetics, pages 100537.
Crossref
Crossref
Gerlinde F. Plöger, Bertil Abrahamsson, Rodrigo Cristofoletti, Dirk W. Groot, Peter Langguth, Mehul U. Mehta, Alan Parr, James E. Polli, Vinod P. Shah, Tomokazu Tajiri & Jennifer B. Dressman. (2018) Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Proguanil Hydrochloride. Journal of Pharmaceutical Sciences 107:7, pages 1761-1772.
Crossref
Crossref
W M Watkins, J D Chulay, D G Sixsmith, H C Spencer & R E Howells. (1987) A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil. Journal of Pharmacy and Pharmacology 39:4, pages 261-265.
Crossref
Crossref
Michael PfallerTimothy Davis. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition
2082
2089
.
J.L.C.M Dorne, K Walton & A.G Renwick. (2003) Polymorphic CYP2C19 and N-acetylation: human variability in kinetics and pathway-related uncertainty factors. Food and Chemical Toxicology 41:2, pages 225-245.
Crossref
Crossref
Chukwuemeka S. Okereke. (1999) Management of HIV-infected pregnant patients in malaria-endemic areas: Therapeutic and safety considerations in concomitant use of antiretroviral and antimalarial agents. Clinical Therapeutics 21:9, pages 1456-1496.
Crossref
Crossref
Unni Jeppesen, Birgitte Buur Rasmussen & Kim Brøsen. (1997) Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanide*. Clinical Pharmacology & Therapeutics 62:3, pages 279-286.
Crossref
Crossref
ANDREW A. SOMOGYI, HELEN A. REINHARD & FELIX BOCHNER. (2008) Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism. British Journal of Clinical Pharmacology 41:3, pages 175-179.
Crossref
Crossref
NA Helsby, G Edwards, AM Breckenridge & SA Ward. (2012) The multiple dose pharmacokinetics of proguanil.. British Journal of Clinical Pharmacology 35:6, pages 653-656.
Crossref
Crossref
J. Wangboonskul, N. J. White, F. Nosten, F. ter Kuile, R. R. Moody & R. B. Taylor. (1993) Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. European Journal of Clinical Pharmacology 44:3, pages 247-251.
Crossref
Crossref
F. von Bruchhausen, S. Ebel, E. Hackenthal, G. Dannhardt, A. W. Frahm, U. Holzgrabe, K. Keller, E. Nürnberg, H. Rimpler, G. Schneider, P. Surmann, H. U. Wolf & G. Wurm. 1993. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis
787
1056
.
NA Helsby, SA Ward, G Edwards, RE Howells & AM Breckenridge. (2012) The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.. British Journal of Clinical Pharmacology 30:4, pages 593-598.
Crossref
Crossref
SA Ward, WM Watkins, E Mberu, JE Saunders, DK Koech, HM Gilles, RE Howells & AM Breckenridge. (2012) Inter‐subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.. British Journal of Clinical Pharmacology 27:6, pages 781-787.
Crossref
Crossref
H.V. Scott, M.D. Edstein, J.R. Veenendaal & K.H. Rieckmann. (1988) A sensitive bioassay for serum cycloguanil using Plasmodium falciparumin vitro. International Journal for Parasitology 18:5, pages 605-609.
Crossref
Crossref
W.M. Watkins, M. Percy, J.M. Crampton, S. Ward, D. Koech & R.E. Howells. (1988) The changing response of Plasmodium falciparum to antimalarial drugs in East Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 82:1, pages 21-26.
Crossref
Crossref
Y Wattanagoon, RB Taylor, RR Moody, NA Ochekpe, S Looareesuwan & NJ White. (2012) Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.. British Journal of Clinical Pharmacology 24:6, pages 775-780.
Crossref
Crossref
R. B. Taylor, R. R. Moody, N. A. Ochekepe & B. Law. (1987) Determination of chlorproguanil and metabolites in biological fluids. Chromatographia 24:1, pages 560-564.
Crossref
Crossref
A. Jaeger, P. Sauder, J. Kopferschmitt & F. Flesch. (2012) Clinical Features and Management of Poisoning due to Antimalarial Drugs. Medical Toxicology 2:4, pages 242-273.
Crossref
Crossref
O.R. Idowu. (1987) Spectrofluorimetric determination of proguanil in biological fluids. Analytica Chimica Acta 199, pages 215-220.
Crossref
Crossref
R.B. Taylor, R.R. Moody & N.A. Ochekpe. (1987) Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 416, pages 394-399.
Crossref
Crossref
M.D. Edstein. (1986) Simultaneous measurement of proguanil and cycloguanil in human plasma by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 380, pages 184-189.
Crossref
Crossref
J.A. Kelly & K.A. Fletcher. (1986) High-performance liquid chromatographic method for the determination of proguanil and cycloguanil in biological fluids. Journal of Chromatography B: Biomedical Sciences and Applications 381, pages 464-471.
Crossref
Crossref
D. E. Worsley. (1985) Plasma Paludrine Levels - Some Observations in Commonwealth Troops in The Far East 1970. Journal of the Royal Army Medical Corps 131:3, pages 148-151.
Crossref
Crossref
I. C. Bygbjerg. (1985) Effect of proguanil and cycloguanil on human lymphocytes in vitro. European Journal of Clinical Pharmacology 28:3, pages 287-290.
Crossref
Crossref
R. Ferone. 1984. Antimalarial Drug II. Antimalarial Drug II
207
221
.
R.R. Moody, A.B. Selkirk & R.B. Taylor. (1980) High-performance liquid chromatography of proguanil, cycloguanil and 4-chlorophenylbiguanide using hydrophobic pairing ion and its application to serum assay. Journal of Chromatography B: Biomedical Sciences and Applications 182:3, pages 359-367.
Crossref
Crossref
. 1972. Antimalarial Agents - Chemistry and Pharmacology. Antimalarial Agents - Chemistry and Pharmacology
233
250
.
Dicran A. Berberian. (1969) Recent advances in malariology. The American Journal of Medicine 46:1, pages 96-117.
Crossref
Crossref
J. HILL. 1963. Experimental Chemotherapy. Experimental Chemotherapy
513
601
.
NEIL HAMILTON FAIRLEY. (1952) THE CHEMOPROPHYLAXIS AND CHEMOTHERAPY OF MALARIA IN MAN WITH SPECIAL REFERENCE TO THE LIFE CYCLE. Australasian Annals of Medicine 1:1, pages 7-17.
Crossref
Crossref
Quentin M. Geiman. (1948) Malaria. New England Journal of Medicine 239:2, pages 58-64.
Crossref
Crossref
RUTH BUTLER, D. G. DAVEY & A. SPINKS. (2012) A PRELIMINARY REPORT OF THE TOXICITY AND THE ASSOCIATED BLOOD CONCENTRATIONS OF PALUDRINE* IN LABORATORY ANIMALS. British Journal of Pharmacology and Chemotherapy 2:3, pages 181-188.
Crossref
Crossref